258 related articles for article (PubMed ID: 29209158)
1. Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease.
Al-Gharaibeh A; Culver R; Stewart AN; Srinageshwar B; Spelde K; Frollo L; Kolli N; Story D; Paladugu L; Anwar S; Crane A; Wyse R; Maiti P; Dunbar GL; Rossignol J
Front Neurosci; 2017; 11():628. PubMed ID: 29209158
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cells derived from the developing forebrain of YAC128 mice exhibit pathological features of Huntington's disease.
Li E; Park HR; Hong CP; Kim Y; Choi J; Lee S; Park HJ; Lee B; Kim TA; Kim SJ; Kim HS; Song J
Cell Prolif; 2020 Oct; 53(10):e12893. PubMed ID: 32865873
[TBL] [Abstract][Full Text] [Related]
3. Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington's Disease.
Gharaibeh A; Maiti P; Culver R; Heileman S; Srinageshwar B; Story D; Spelde K; Paladugu L; Munro N; Muhn N; Kolli N; Rossignol J; Dunbar GL
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333883
[TBL] [Abstract][Full Text] [Related]
4. In Vivo Roles of a Patient-Derived Induced Pluripotent Stem Cell Line (HD72-iPSC) in the YAC128 Model of Huntington's Disease.
Jeon I; Choi C; Lee N; Im W; Kim M; Oh SH; Park IH; Kim HS; Song J
Int J Stem Cells; 2014 May; 7(1):43-7. PubMed ID: 24921027
[TBL] [Abstract][Full Text] [Related]
5. Human iPSC-derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington's disease mouse model.
Park HJ; Jeon J; Choi J; Kim JY; Kim HS; Huh JY; Goldman SA; Song J
Cell Prolif; 2021 Aug; 54(8):e13082. PubMed ID: 34152047
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.
Zhang N; An MC; Montoro D; Ellerby LM
PLoS Curr; 2010 Oct; 2():RRN1193. PubMed ID: 21037797
[TBL] [Abstract][Full Text] [Related]
7. Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease.
Silva AC; Ferreira IL; Hayden MR; Ferreiro E; Rego AC
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):34-44. PubMed ID: 28939435
[TBL] [Abstract][Full Text] [Related]
8. Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis.
Fink KD; Rossignol J; Crane AT; Davis KK; Bombard MC; Bavar AM; Clerc S; Lowrance SA; Song C; Lescaudron L; Dunbar GL
Stem Cell Res Ther; 2013 Oct; 4(5):130. PubMed ID: 24456799
[TBL] [Abstract][Full Text] [Related]
9. Transplantation of patient-derived adipose stem cells in YAC128 Huntington's disease transgenic mice.
Im W; Lee ST; Park JE; Oh HJ; Shim J; Lim J; Chu K; Kim M
PLoS Curr; 2010 Sep; 2():. PubMed ID: 20890444
[TBL] [Abstract][Full Text] [Related]
10. YAC128 mouse model of Huntington disease is protected against subtle chronic manganese (Mn)-induced behavioral and neuropathological changes.
Wilcox JM; Pfalzer AC; Tienda AA; Debbiche IF; Cox EC; Totten MS; Erikson KM; Harrison FE; Bowman AB
Neurotoxicology; 2021 Dec; 87():94-105. PubMed ID: 34543681
[TBL] [Abstract][Full Text] [Related]
11. Intrastriatal transplantation of adenovirus-generated induced pluripotent stem cells for treating neuropathological and functional deficits in a rodent model of Huntington's disease.
Fink KD; Crane AT; Lévêque X; Dues DJ; Huffman LD; Moore AC; Story DT; Dejonge RE; Antcliff A; Starski PA; Lu M; Lescaudron L; Rossignol J; Dunbar GL
Stem Cells Transl Med; 2014 May; 3(5):620-31. PubMed ID: 24657963
[TBL] [Abstract][Full Text] [Related]
12. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Van Raamsdonk JM; Pearson J; Slow EJ; Hossain SM; Leavitt BR; Hayden MR
J Neurosci; 2005 Apr; 25(16):4169-80. PubMed ID: 15843620
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of Induced Pluripotent Stem Cell-Derived Neural Stem Cells Mediate Functional Recovery Following Thoracic Spinal Cord Injury Through Remyelination of Axons.
Salewski RP; Mitchell RA; Li L; Shen C; Milekovskaia M; Nagy A; Fehlings MG
Stem Cells Transl Med; 2015 Jul; 4(7):743-54. PubMed ID: 25979861
[TBL] [Abstract][Full Text] [Related]
14. Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease.
Stanek LM; Yang W; Angus S; Sardi PS; Hayden MR; Hung GH; Bennett CF; Cheng SH; Shihabuddin LS
J Huntingtons Dis; 2013; 2(2):217-28. PubMed ID: 25063516
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral Transplantation of BDNF-overexpressing Human Neural Stem Cells (HB1.F3.BDNF) Promotes Migration, Differentiation and Functional Recovery in a Rodent Model of Huntington's Disease.
Kim HS; Jeon I; Noh JE; Lee H; Hong KS; Lee N; Pei Z; Song J
Exp Neurobiol; 2020 Apr; 29(2):130-137. PubMed ID: 32408403
[TBL] [Abstract][Full Text] [Related]
16. Implantation of the clinical-grade human neural stem cell line, CTX0E03, rescues the behavioral and pathological deficits in the quinolinic acid-lesioned rodent model of Huntington's disease.
Yoon Y; Kim HS; Jeon I; Noh JE; Park HJ; Lee S; Park IH; Stevanato L; Hicks C; Corteling R; Barker RA; Sinden JD; Song J
Stem Cells; 2020 Aug; 38(8):936-947. PubMed ID: 32374064
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation for Huntington's diseases.
Choi KA; Choi Y; Hong S
Methods; 2018 Jan; 133():104-112. PubMed ID: 28867501
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of TRPC1-Dependent Store-Operated Calcium Entry Improves Synaptic Stability and Motor Performance in a Mouse Model of Huntington's Disease.
Wu J; Ryskamp D; Birnbaumer L; Bezprozvanny I
J Huntingtons Dis; 2018; 7(1):35-50. PubMed ID: 29480205
[TBL] [Abstract][Full Text] [Related]
19. Neural Transplants From Human Induced Pluripotent Stem Cells Rescue the Pathology and Behavioral Defects in a Rodent Model of Huntington's Disease.
Yoon Y; Kim HS; Hong CP; Li E; Jeon I; Park HJ; Lee N; Pei Z; Song J
Front Neurosci; 2020; 14():558204. PubMed ID: 33071737
[TBL] [Abstract][Full Text] [Related]
20. Combination of stem cell and gene therapy ameliorates symptoms in Huntington's disease mice.
Cho IK; Hunter CE; Ye S; Pongos AL; Chan AWS
NPJ Regen Med; 2019; 4():7. PubMed ID: 30937182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
